Insider Trading Alert - CNP, MTEX And TRC Traded By Insiders

Yesterday, Nov. 18, 2015, 127 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.29 to $228,091,773.00.

Highlighted Stocks Traded by Insiders:

CenterPoint Energy (CNP) - FREE Research Report

Longoria Janiece M, who is Director at CenterPoint Energy, sold 3,000 shares at $17.03 on Nov. 18, 2015. Following this transaction, the Director owned 52,340 shares meaning that the stake was reduced by 5.42% with the 3,000-share transaction.

The shares most recently traded at $17.08, up $0.05, or 0.28% since the insider transaction. Historical insider transactions for CenterPoint Energy go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 9,795
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 9,795
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 9,795

The average volume for CenterPoint Energy has been 4.3 million shares per day over the past 30 days. CenterPoint Energy has a market cap of $7.3 billion and is part of the utilities sector and utilities industry. Shares are down 26.76% year-to-date as of the close of trading on Wednesday.

CenterPoint Energy, Inc. operates as a public utility holding company in the United States. The stock currently has a dividend yield of 5.8%. Currently, there are 4 analysts who rate CenterPoint Energy a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNP - FREE

TheStreet Quant Ratings rates CenterPoint Energy as a hold. The company's strongest point has been its expanding profit margins. At the same time, however, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full CenterPoint Energy Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mannatech (MTEX) - FREE Research Report

Bala Alfredo, who is CEO and President at Mannatech, sold 675 shares at $19.08 on Nov. 18, 2015. Following this transaction, the CEO and President owned 11,158 shares meaning that the stake was reduced by 5.7% with the 675-share transaction.

The shares most recently traded at $19.85, up $0.77, or 3.88% since the insider transaction. Historical insider transactions for Mannatech go as follows:

  • 4-Week # shares bought: 3,827
  • 4-Week # shares sold: 709
  • 12-Week # shares bought: 3,827
  • 12-Week # shares sold: 709
  • 24-Week # shares bought: 3,827
  • 24-Week # shares sold: 709

The average volume for Mannatech has been 14,700 shares per day over the past 30 days. Mannatech has a market cap of $51.9 million and is part of the consumer goods sector and consumer non-durables industry. Shares are down 27.32% year-to-date as of the close of trading on Wednesday.

Mannatech, Incorporated develops and sells health products. Its health products include nutritional supplements, health solutions for children, and additional nutrients. The company also offers weight and fitness products; and topical, skin care, and anti-aging products. The company has a P/E ratio of 8.5. Currently, there are no analysts who rate Mannatech a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MTEX - FREE

TheStreet Quant Ratings rates Mannatech as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and attractive valuation levels. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Mannatech Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tejon Ranch (TRC) - FREE Research Report

Towerview Llc, who is Director at Tejon Ranch, bought 13,545 shares at $20.93 on Nov. 18, 2015. Following this transaction, the Director owned 2.7 million shares meaning that the stake was boosted by 0.5% with the 13,545-share transaction.

The shares most recently traded at $21.82, up $0.89, or 4.07% since the insider transaction. Historical insider transactions for Tejon Ranch go as follows:

  • 4-Week # shares bought: 429
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 64,431
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 83,841
  • 24-Week # shares sold: 1,000

The average volume for Tejon Ranch has been 33,400 shares per day over the past 30 days. Tejon Ranch has a market cap of $431.6 million and is part of the financial sector and real estate industry. Shares are down 26.58% year-to-date as of the close of trading on Wednesday.

Tejon Ranch Co. operates as a diversified real estate development and agribusiness company. The company operates through four segments: Commercial/Industrial Real Estate Development, Resort/Residential Real Estate Development, Mineral Resources, and Farming. The company has a P/E ratio of 139.1. Currently, there are no analysts who rate Tejon Ranch a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRC - FREE

TheStreet Quant Ratings rates Tejon Ranch as a hold. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income. Get the full Tejon Ranch Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

Stocks End Close to Home

Stocks End Close to Home

Jim Cramer on Bank of America, Tariffs and the Goldman Sachs CEO Change

Jim Cramer on Bank of America, Tariffs and the Goldman Sachs CEO Change